5-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-7-chloro-2-methylindol-3-yl]-N,N-dimethylpyridine-3-sulfonamide
C20H22ClFN4O2S — CID 130302749
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-7-chloro-2-methylindol-3-yl]-N,N-dimethylpyridine-3-sulfonamide
5-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-7-chloro-2-methylindol-3-yl]-N,N-dimethylpyridine-3-sulfonamide (PubChem CID 130302749) has the molecular formula C20H22ClFN4O2S and a molecular weight of 436.94 g/mol. Its IUPAC name is 5-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-7-chloro-2-methylindol-3-yl]-N,N-dimethylpyridine-3-sulfonamide.
Molecular Properties
| Compound Name | 5-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-7-chloro-2-methylindol-3-yl]-N,N-dimethylpyridine-3-sulfonamide |
|---|---|
| PubChem CID | 130302749 |
| Molecular Formula | C20H22ClFN4O2S |
| Molecular Weight | 436.94 g/mol |
| Exact Mass | 436.11 |
| IUPAC Name | 5-[1-[(Z)-4-amino-2-fluorobut-2-enyl]-7-chloro-2-methylindol-3-yl]-N,N-dimethylpyridine-3-sulfonamide |
| SMILES | Cc1c(-c2cncc(S(=O)(=O)N(C)C)c2)c2cccc(Cl)c2n1C/C(F)=C/CN |
| InChI | InChI=1S/C20H22ClFN4O2S/c1-13-19(14-9-16(11-24-10-14)29(27,28)25(2)3)17-5-4-6-18(21)20(17)26(13)12-15(22)7-8-23/h4-7,9-11H,8,12,23H2,1-3H3/b15-7- |
| InChIKey | DMQBNXWLVZYSHY-CHHVJCJISA-N |
| XLogP | 3.73 |
| TPSA | 81.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.94 |
| LogP ≤ 5 | 3.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130302749 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.